Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature Medicine

• Publication date

  2002-08-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nm748PMID 12172542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells.

  2002cited by this paper
• The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R

  2002cited by this paper
• Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

  2002cited by this paper
• Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.

  2001cited by this paper
• Lipoxins: revelations on resolution.

  2001cited by this paper
• Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells.

  2001cited by this paper
• Lipid mediator class switching during acute inflammation: signals in resolution

  2001cited by this paper
• Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking1

  2000cited by this paper
• Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways.

  2000cited by this paper
• Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

  2000cited by this paper
• Eosinophils generate brominating oxidants in allergen-induced asthma.

  2000cited by this paper
• Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

  2000cited by this paper
• Heterogeneity of therapeutic responses in asthma.

  2000cited by this paper
• Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics.

  2000cited by this paper
• Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1

  2000cited by this paper
• Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways

  2000cited by this paper
• Asthma. From bronchoconstriction to airways inflammation and remodeling.

  2000cited by this paper
• Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1

  2000cited by this paper
• Treatment of asthma with drugs modifying the leukotriene pathway.

  1999cited by this paper
• The epidemic of allergy and asthma

  1999cited by this paper
• Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice.

  1999cited by this paper
• Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation.

  1999cited by this paper
• Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.

  1999cited by this paper
• Contribution of Nitric Oxide Synthases 1, 2, and 3 to Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma

  1999cited by this paper
• IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils.

  1999cited by this paper
• Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.

  1999cited by this paper
• Leukotrienes as mediators of airway obstruction.

  1998cited by this paper
• Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

  1997cited by this paper
• Lipid mediator networks in cell signaling: update and impact of cytokines 1

  1996cited by this paper
• Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet‐activating factor and N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanine

  1994cited by this paper
• Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

  1992cited by this paper
• Cytokines in symptomatic asthma airways.

  1992cited by this paper
• The effects of lipoxin A4 on airway responses in asthmatic subjects.

  1992cited by this paper
• Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases.

  1990cited by this paper
• Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.

  1989cited by this paper
• Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo.

  1988cited by this paper
• FROM STUDIES OF BIOCHEMICAL MECHANISMS TO NEW BIOLOGICAL MEDIATORS: PROSTAGLANDIN ENDOPEROXIDES, THROMBOXANES, AND LEUKOTRIENES

  1984cited by this paper
• From studies of biochemical mechanism to novel biological mediators: Prostaglandin endoperoxides, thromboxanes, and leukotriences

  1983cited by this paper

• Interleukin-35 inhibits NETs to ameliorate Th17/Treg immune imbalance during the exacerbation of cigarette smoke exposed-asthma via gp130/STAT3/ferroptosis axis

  2025cites this paper
• Eosinophils and pleural macrophages counter regulate IL-33-elicited airway inflammation via the 12/15-lipoxygenase pathway

  2025cites this paper
• Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications

  2025cites this paper
• Aerosolized Harmful Algal Bloom Toxin Microcystin-LR Induces Type 1/Type 17 Inflammation of Murine Airways

  2024cites this paper
• Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation.

  2024cites this paper
• The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).

  2023cites this paper
• Pulmonary surfactant-derived antiviral actions at the respiratory surface

  2023cites this paper
• Resolvins and Cysteinyl-containing Pro-Resolving Mediators Activate Resolution of Infectious Inflammation and Tissue Regeneration.

  2023cites this paper
• Effect of lipoxin A4 on the osteogenic differentiation of periodontal ligament stem cells under lipopolysaccharide-induced inflammatory conditions.

  2023cites this paper
• P2X7 signaling influences the production of pro-resolving and pro-inflammatory lipid mediators in alveolar macrophages derived from individuals with asthma.

  2023cites this paper
• LXA4 inhibits TGF-β1-induced airway smooth muscle cells proliferation and migration by suppressing the Smad/YAP pathway.

  2023cites this paper
• Targeting Neutrophils for Promoting the Resolution of Inflammation

  2022cites this paper
• Resolution of inflammation: Intervention strategies and future applications.

  2022cites this paper
• Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy

  2022cites this paper
• Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation.

  2022cites this paper
• CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators

  2022cites this paper
• Nanotherapeutics in the treatment of acute respiratory distress syndrome

  2021cites this paper
• Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease

  2021influential citation
• NK cells and lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge

  2021cites this paper
• Lipoxin A4 inhibits ovalbumin-induced airway inflammation and airway remodeling in a mouse model of asthma.

  2021cites this paper
• Role of formyl peptide receptor 2 (FPR2) in modulating immune response and heart inflammation in an experimental model of acute and chronic Chagas disease.

  2021cites this paper
• Resolution of inflammation: An organizing principle in biology and medicine.

  2021cites this paper
• Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids

  2021influential citation
• The Role of Innate Lymphoid Cells in Chronic Respiratory Diseases

  2021cites this paper
• 12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice

  2021cites this paper
• Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases

  2021cites this paper
• Eicosanoid receptors as therapeutic targets for asthma.

  2021cites this paper
• EXPERIMENTAL STUDIES OF LIPID MEDIATOR MODULATION OF AIRWAY RESPONSIVENESS

  2021cites this paper
• MicroRNAs in shaping the resolution phase of inflammation.

  2021cites this paper
• Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy?

  2020influential citation
• Lipidmediatoren und ihre Rolle bei Entzündungen und Allergien

  2020cites this paper
• Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergic diseases.

  2020cites this paper
• Lipoxin A4 reduces house dust mite and TNFα-induced hyperreactivity in the mouse trachea.

  2020cites this paper
• Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease.

  2020cites this paper
• Lipid mediators and asthma: scope of therapeutics.

  2020cites this paper
• Formyl peptide receptors in the mucosal immune system

  2020cites this paper
• Anticancer therapeutics: a brief account on wide refinements.

  2020cites this paper
• Targeting the OXE receptor as a potential novel therapy for asthma.

  2020cites this paper
• The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.

  2020cites this paper
• Treatment options in type-2 low asthma

  2020cites this paper
• Evaluation of Lipoxin A4 as A Marker of Severity of Bronchial Asthma in Pediatrics in Zagazig University Hospital

  2020cites this paper
• Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation.

  2020cites this paper
• Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases

  2019cites this paper
• Effect of chiropractic manipulation on disrupted epithelium barrier and its mechanism of specialized pro-resolving mediators in a spleen-deficiency murine model.

  2019cites this paper
• Oxygenated Lipid Products in COPD and Asthma: A Clinical Picture

  2019cites this paper
• Lipoxin A4 attenuates hyperoxia‑induced lung epithelial cell injury via the upregulation of heme oxygenase‑1 and inhibition of proinflammatory cytokines.

  2019cites this paper
• Lipoxin suppresses inflammation via the TLR4/MyD88/NF‐κB pathway in periodontal ligament cells

  2019cites this paper
• Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease

  2019cites this paper
• Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1.

  2019cites this paper
• Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review

  2019cites this paper
• Concise Review: Pro-Resolving Lipid Mediators and Receptors in Stem Cell Biology.

  2019cites this paper
• Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome

  2019cites this paper
• Is lipoxin A4 an effective treatment on fat embolism syndrome by attenuating pro-inflammatory response?

  2019cites this paper
• Dysregulated fatty acid metabolism in nasal polyp‐derived eosinophils from patients with chronic rhinosinusitis

  2019cites this paper
• Allergen Sensitization and Asthma Outcomes among World Trade Center Rescue and Recovery Workers

  2019cites this paper
• A composite of exhaled LTB4, LXA4, FeNO, and FEV1 as an “asthma classification ratio” characterizes childhood asthma

  2018cites this paper
• Effects of Lipoxin A 4 Receptor Agonist and Interleukin鄄 1 茁 in Toll鄄Like Receptors / Mycloid Differentiation Factor 88 / Nuclear Factor鄄资B Signal Pathway on Asthma Mice with Airway Inflammation

  2018influential citation
• Identification of differentially expressed genes in childhood asthma

  2018cites this paper
• Leukocyte CD300a Contributes to the Resolution of Murine Allergic Inflammation

  2018cites this paper
• Leprosy and its reactional episodes: Serum levels and possible roles of omega‐3 and omega‐6‐derived lipid mediators

  2018cites this paper
• Towards targeting resolution pathways of airway inflammation in asthma

  2018cites this paper
• Eicosanoid Control Over Antigen Presenting Cells in Asthma

  2018cites this paper
• Identification and structure elucidation of the pro‐resolving mediators provides novel leads for resolution pharmacology

  2018cites this paper
• Crotoxin Isolated from Crotalus durissus terrificus Venom Modulates the Functional Activity of Dendritic Cells via Formyl Peptide Receptors

  2018cites this paper
• Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort

  2018cites this paper
• Immunoresolvents in asthma and allergic diseases: Review and update

  2018cites this paper
• Deficiency in Fpr2 results in reduced numbers of Lin−cKit+Sca1+ myeloid progenitor cells

  2018cites this paper
• Flexibility and strength training in asthma: A pilot study

  2018cites this paper
• Amendment history : Corrigendum ( March 2018 ) ALX receptor ligands define a biochemical endotype for severe asthma

  2018cites this paper
• Targeting formyl peptide receptors to facilitate the resolution of inflammation.

  2018cites this paper
• Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

  2018cites this paper
• Addressing unmet needs in understanding asthma mechanisms

  2017cites this paper
• United States Patent Serhan

  2017cites this paper
• Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.

  2017cites this paper
• Natural killer cell–mediated inflammation resolution is disabled in severe asthma

  2017cites this paper
• Inflammatory Cellular Patterns in Asthma

  2017cites this paper
• Mast cell and eosinophil surface receptors as targets for anti‐allergic therapy

  2017cites this paper
• Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation.

  2017cites this paper
• Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.

  2017cites this paper
• Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast

  2016cites this paper
• Bigelovii A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Blocking NF-κB and CCAAT/Enhancer-Binding Protein δ Pathways

  2016cites this paper
• Lipid Mediators in Inflammation

  2016influential citation
• Type 2 innate lymphoid cells: at the cross-roads in allergic asthma

  2016cites this paper
• Increased Postexercise Lipoxin A4 Levels in Exhaled Breath Condensate in Asthmatic Children With Exercise-Induced Bronchoconstriction.

  2016cites this paper
• Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.

  2016cites this paper
• Leukotriene Receptor Antagonists and FLAP Inhibitors

  2016cites this paper
• Type 2 innate lymphoid cells: at the cross-roads in allergic asthma

  2016cites this paper
• Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.

  2016cites this paper
• Blood biomarker panels of the late phase asthmatic response

  2016cites this paper
• BML-111 attenuates acute lung injury in endotoxemic mice.

  2016cites this paper
• Protective effect of soybean oil- or fish oil-rich diets on allergic airway inflammation

  2016cites this paper
• n-3 Fatty acids and asthma

  2016cites this paper
• Médiateurs lipidiques pro-résolvant dans l’inflammation allergique

  2016cites this paper
• Lipoxins, Resolvins, and the Resolution of Inflammation

  2016cites this paper
• Specialized pro-resolving mediators: endogenous regulators of infection and inflammation

  2015cites this paper
• Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.

  2015cites this paper
• FPR2/ALX activation reverses LPS-induced vascular hyporeactivity in aorta and increases survival in a pneumosepsis model.

  2015cites this paper
• Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

  2015cites this paper
• Innate immunity is a key factor for the resolution of inflammation in asthma

  2015cites this paper
• Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

  2015cites this paper